Akimika 500mg Injection
Marketer
Global Care
Salt Composition
Amikacin (500mg)
Overview Akimika 500mg Injection
InfectiGuard 500mg Injection, a broad-spectrum antibiotic, combats diverse bacterial infections affecting various body systems, including the urinary tract, musculoskeletal system, respiratory system (like pneumonia), central nervous system, and bloodstream. Prophylactically, it's used in hospitalized individuals to avert infections. Its mechanism involves bacterial growth inhibition. Administered intravenously (IV drip) or intramuscularly by a healthcare provider, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; omitting doses or prematurely ceasing treatment risks infection recurrence or exacerbation. Common adverse effects comprise injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy necessitate medical consultation. High doses may induce disequilibrium, nephrotoxicity, and ototoxicity; hence, close monitoring, including kidney function, hearing, and urine tests, may be implemented. Pregnancy contraindicates its use; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Akimika 500mg Injection
Infections caused by bacteria
Major Benefits of Akimika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Akimika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Akimika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Akimika 500mg Injection works:
Akimika 500mg Injection is a bacterial growth inhibitor, functioning as an antibiotic by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Akimika 500mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering Akimika 500mg Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Akimika 500mg poses no known risk during lactation. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
The administration of Akimika 500mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Refrain from operating a vehicle should any of these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, administering Akimika 500mg Injection requires careful consideration. Dosage modification of Akimika 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Akimika 500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Akimika 500mg Injection :
Should you forget a dose of Akimika 500mg Injection, seek medical advice.
Facts to Know About Akimika 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently